Skip to main content
Clinical Trials/KCT0003063
KCT0003063
Terminated
未知

Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)

Asan Medical Center0 sites400 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Asan Medical Center
Enrollment
400
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • The patient must be at least 19 years of age.
  • Significant native coronary artery stenosis (\>50% by visual estimate) with lesion length of more than 25mm, which requiring at long stent placement without intervening normal segment.
  • Patients with silent ischemia, stable or unstable angina pectoris, ad Non\-ST\-elevation myocardial infarction (NSTEMI)
  • The patient or guardian agrees to the study protocol and the schedule of clinical and angiographic follow\-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethical Committee of the respective clinical site.

Exclusion Criteria

  • Any contraindication to any of the following medications: aspirin, heparin, clopidogrel, stainless steel, contrast agents, sirolimus, or everolimus
  • An elective surgical procedure is planned that would necessitate interruption of antiplatelet drugs during the first 6 months post enrollment.
  • Acute ST\-segment\-elevation MI or cardiogenic shock
  • Terminal illness with life expectancy \<1 year
  • In\-stent restenosis at target vessel (either bare metal stent or drug\-eluting stent segment). However, non\-target vessel ISR is permitted.
  • Patients with EF\<30%.
  • Serum creatinine level \= 2\.0mg/dL or dependence on dialysis.
  • Patients with left main stem stenosis (\>50% by visual estimate)

Outcomes

Primary Outcomes

Not specified

Similar Trials